×
About 3,836 results

ALLMedicine™ Anaplastic Large Cell Lymphoma Center

Research & Reviews  1,805 results

Leukaemic relapse of anaplastic large cell lymphoma, ALK negative.
https://doi.org/10.1136/bcr-2020-239213
BMJ Case Reports; Karki NR, Badin K et. al.

Feb 23rd, 2021 - Anaplastic large cell lymphoma (ALCL), ALK negative (ALK-) is an aggressive lymphoproliferative disorder of mature T lymphocytes characterised by hallmark cells, CD30 positivity and lacking ALK protein expression. ALCL, ALK- has to be differentiat...

Management of Asymptomatic Patients With Textured Breast Implants: A Survey Analysis of...
https://doi.org/10.1093/asj/sjab101
Aesthetic Surgery Journal; Frojo G, Nguyen D et. al.

Feb 22nd, 2021 - The management of Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL) has been well established. However, there is minimal data and significant variability in the management of asymptomatic textured implant (ATI) patients. The purp...

MDMX/MDM4 is highly expressed and contributes to cell growth and survival in anaplastic...
https://doi.org/10.1080/10428194.2021.1876871
Leukemia & Lymphoma; Sinatkas V, Stathopoulou K et. al.

Feb 11th, 2021 - We hypothesized that murine double minute X (MDMX), a negative p53-regulator, may be involved in dysfunctional p53-signaling in anaplastic large cell lymphoma (ALCL), anaplastic lymphoma kinase (ALK)-positive and ALK-negative, characterized freque...

Sarcoidosis Presenting as Late Seroma Mimicking Breast Implant-Associated Anaplastic La...
https://doi.org/10.1097/SAP.0000000000002684
Annals of Plastic Surgery; Ibarra G, Vallejo A et. al.

Feb 9th, 2021 - Late seroma related to breast silicone implants is a rare complication. Interest for its characterization has grown after its association with the recently described breast implant-associated anaplastic large cell lymphoma. The differential diagno...

ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876884
Blood Advances; Shustov A, Cabrera ME et. al.

Feb 9th, 2021 - Anaplastic lymphoma kinase-negative anaplastic large cell lymphoma (ALK- ALCL) is an aggressive neoplasm of T-cell/null-cell lineage. The T-Cell Project is a global prospective cohort study that consecutively enrolled patients newly diagnosed with...

see more →

Guidelines  5 results

Best Practices Guideline for the Pathologic Diagnosis of Breast Implant-Associated Anap...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106983
Journal of Clinical Oncology : Official Journal of the Am... Jaffe ES, Ashar BS et. al.

Feb 11th, 2020 - To provide guidelines for the accurate pathologic diagnosis of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), the preoperative evaluation of the patient with suspected BIA-ALCL, and the pathologic evaluation of the capsulecto...

Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL) - Letter to Health Care Providers
https://www.fda.gov/MedicalDevices/Safety/LetterstoHealthCareProviders/ucm630863.htm
FDA

Feb 5th, 2019 - The Food and Drug Administration (FDA) wants to increase awareness about an association between all breast implants, regardless of filling or texture, and Breast Implant Associated- Anaplastic Large Cell Lymphoma (BIA-ALCL). The FDA received repor...

Genetics of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
https://academic.oup.com/asj/article/39/Supplement_1/S14/5304915
Oishi,N.,et al

Jan 30th, 2019 - Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a newly included provisional entity in the 2016 revision of the World Health Organization classification, is a distinct form of CD30-positive T-cell non-Hodgkin lymphoma that ari...

2019 NCCN Consensus Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
https://academic.oup.com/asj/article/39/Supplement_1/S3/5304919
Clemens,M.,et al

Jan 30th, 2019 - National Comprehensive Cancer Network (NCCN) guidelines represent the consensus standard of care for diagnosis and management of the majority of known cancers. NCCN guidelines on breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) ...

NCCN Consensus Guidelines for the Diagnosis and Management of Breast Implant-Associated...
https://doi.org/10.1093/asj/sjw259
Aesthetic Surgery Journal; Clemens MW, Horwitz SM

Feb 11th, 2017 - Published case series demonstrate a lack of treatment standardization for breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) with a wide variety of therapeutic strategies being employed at all stages of disease. The National Compr...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  1,923 results

Leukaemic relapse of anaplastic large cell lymphoma, ALK negative.
https://doi.org/10.1136/bcr-2020-239213
BMJ Case Reports; Karki NR, Badin K et. al.

Feb 23rd, 2021 - Anaplastic large cell lymphoma (ALCL), ALK negative (ALK-) is an aggressive lymphoproliferative disorder of mature T lymphocytes characterised by hallmark cells, CD30 positivity and lacking ALK protein expression. ALCL, ALK- has to be differentiat...

Management of Asymptomatic Patients With Textured Breast Implants: A Survey Analysis of...
https://doi.org/10.1093/asj/sjab101
Aesthetic Surgery Journal; Frojo G, Nguyen D et. al.

Feb 22nd, 2021 - The management of Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL) has been well established. However, there is minimal data and significant variability in the management of asymptomatic textured implant (ATI) patients. The purp...

MDMX/MDM4 is highly expressed and contributes to cell growth and survival in anaplastic...
https://doi.org/10.1080/10428194.2021.1876871
Leukemia & Lymphoma; Sinatkas V, Stathopoulou K et. al.

Feb 11th, 2021 - We hypothesized that murine double minute X (MDMX), a negative p53-regulator, may be involved in dysfunctional p53-signaling in anaplastic large cell lymphoma (ALCL), anaplastic lymphoma kinase (ALK)-positive and ALK-negative, characterized freque...

Sarcoidosis Presenting as Late Seroma Mimicking Breast Implant-Associated Anaplastic La...
https://doi.org/10.1097/SAP.0000000000002684
Annals of Plastic Surgery; Ibarra G, Vallejo A et. al.

Feb 9th, 2021 - Late seroma related to breast silicone implants is a rare complication. Interest for its characterization has grown after its association with the recently described breast implant-associated anaplastic large cell lymphoma. The differential diagno...

ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876884
Blood Advances; Shustov A, Cabrera ME et. al.

Feb 9th, 2021 - Anaplastic lymphoma kinase-negative anaplastic large cell lymphoma (ALK- ALCL) is an aggressive neoplasm of T-cell/null-cell lineage. The T-Cell Project is a global prospective cohort study that consecutively enrolled patients newly diagnosed with...

see more →

News  101 results

NICE: Brentuximab Vedotin for Untreated sALCL
https://www.staging.medscape.com/viewarticle/933703

Jul 9th, 2020 - The National Institute for Health and Care Excellence (NICE) has published final draft guidance recommending brentuximab vedotin (Adcetris, Takeda) with cyclophosphamide, doxorubicin, and prednisone (CHP) for untreated systemic anaplastic large ce...

NICE: Brentuximab Vedotin for Untreated sALCL
https://www.medscape.com/viewarticle/933703

Jul 9th, 2020 - The National Institute for Health and Care Excellence (NICE) has published final draft guidance recommending brentuximab vedotin (Adcetris, Takeda) with cyclophosphamide, doxorubicin, and prednisone (CHP) for untreated systemic anaplastic large ce...

Number of Cases of Breast Implant-linked Lymphoma in the UK
https://www.medscape.com/viewarticle/933637

Jul 8th, 2020 - As of April 2020, there have been 68 cases of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) reported in the UK. This figure includes cases where the original implantation did not occur in the UK. Based on the number of cases,...

Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL) - Letter to Health Care Providers | FDA
https://www.fda.gov/medical-devices/letters-health-care-providers/breast-implant-associated-anaplastic-large-cell-lymphoma-bia-alcl-letter-health-care-providers

The information in this letter has been superseded by The FDA Takes Action to Protect Patients from Risk of Certain Textured Breast Implants; Requests Allergan Voluntarily Recall Certain Breast Implants and Tissue Expanders from the Market: FDA Sa...

Breast Implant and Blood Cancer Advice Updated
https://www.medscape.com/viewarticle/899959

Aug 21st, 2019 - Health professionals have been reminded to continue to report suspected cases of breast implant associated-anaplastic large cell lymphoma (BIA-ALCL) in patients who have had breast implants or who have had them removed. In an update to two previou...

see more →